The IQVIA Podcast

In this episode of Healthcare Talks, we explore the real-world experiences of patients using obesity medications, including GLP-1 treatments, in Belgium. Beyond the headlines, we discuss treatment adherence, side effects, costs, and the behavioral factors that influence long-term success. Join us as we uncover the gap between clinical expectations and everyday patient reality, and the important ro...

In this episode of the IQVIA MedTech Business Insights Podcast, Michelle Edwards speaks with Arvind Ramadore, Global Head of Innovations for Robotic Surgery Technologies at Medtronic, to discuss how robotics and AI are reshaping the future of surgery.  Their conversation explores the opportunities and challenges facing the industry, from evidence generation and reimbursement to regulation, digital...

This episode explores how pharmaceutical engagement will evolve as AI increasingly becomes the first port of call for HCPs to access medical information and guidelines. Learn how investments must shift as share of algorithmic trust becomes a key battleground, and how in-field roles will need to evolve to provide deeper, more consultative engagements.

In this episode of the IQVIA podcast, Daniel Mora-Brito, Engagement Manager, Global Health, Thought Leadership, examines the growing urgency of addressing obesity as a central driver of noncommunicable diseases (NCDs), particularly in low- and middle-income countries (LMICs) and what is at stake if action is delayed. Joined by Johanna Ralston, CEO, World Obesity Federation; Claudia Martínez, Direc...

Artificial Intelligence (AI) is no longer a futuristic concept in life sciences—it’s here, transforming drug safety and pharmacovigilance at an unprecedented pace. But as the industry embraces automation and advanced analytics, one truth stands firm: innovation without governance is a risk no one can afford. In this episode of The Top Line, we explore how AI is reshaping drug safety while governan...

Join IQVIA Thought Leaders, Sarah Rickwood and Kirstie Scott as they discuss key changes in the launch environment. Hear about the rising importance of the private market (led by, but not limited to obesity medications) and how pharma must quickly adapt to AI-enabled HCP self-empowerment.

In this episode, Dr. Paul Beresford, Senior Vice President of Biopharma Partnerships at PathAI, shares perspectives on how artificial intelligence is transforming pathology workflows, enhancing diagnostic accuracy, and supporting precision medicine. Discover practical insights on AI integration, regulatory alignment, and the evolving partnership between technology and clinical expertise in diagnos...

In this episode, Stefan Lutzmayer, from IQVIA’s EMEA Thought Leadership team, speaks with Özgür Tuncer, CEO & Executive Director of Stablepharma, about the growing complexity of the pharmaceutical cold chain and how innovation could make it more resilient, sustainable, and accessible. IQVIA’s EMEA Thought Leadership team analyses major trends shaping the pharmaceutical market and their implica...

Welcome to “Debunking Value, Access & Pricing Myths”—a podcast series from IQVIA’s Value and Payer Evidence team where we explore the transformations underway in healthcare pricing and market access - challenging outdated norms and shedding light on the new realities shaping our work. In the second episode, your host Rebecca Coady, Principal at IQVIA, is joined by her colleague Katrin Lamp. To...

In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the importance of target product profiles, particularly when navigating funding challenges, with Ian Fisher, head of development analytics.

In this episode, BioSpace’s head of insights Lori Ellis discusses how AI transformation can help organizations navigate a rapidly evolving regulatory environment with senior director of regulatory innovation and technology, Michelle Gyzen.

In this episode, BioSpace’s head of insights Lori Ellis discusses the FDA’s first draft guidance for AI in drug development, published in January 2025, with Archana Hegde, Senior Director, PV systems and innovations at IQVIA.

In this episode, BioSpace’s head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with ⁠Ana Pedro Jesuíno⁠, global head local QPPV network at IQVIA.

In this episode, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of patient data driving AI tasks with Louise Molloy, associate director medical information and pharmacovigilance.

This episode focuses on how Agentic AI is shaping the future of clinical research.  In this episode you will:   Learn about the differences between an AI agent and an agentic framework and how the latter can coordinate and orchestrate many different AI agents to answer more complex questions.   Explore the capabilities of Agentic AI and its applications in clinical trials and early clinical develo...

Welcome to “Debunking Value, Access & Pricing Myths”—a podcast series from IQVIA’s Value and Payer Evidence team where we separate fact from fiction on some of the most persistent misconceptions in the world of healthcare pricing and access. In this debut episode, your host Rebecca Coady, Principal at IQVIA, is joined by her colleague and EU HTA expert, Sian Tanner. Together, they take on a my...

This episode focuses on how IQVIA is innovating with agentic AI to drive efficiency and quality in clinical trials.    In this episode you will:    Discover how agentic AI can be leveraged to enhance efficiency and quality in clinical trials and help increase the chance of success.  See how an agentic AI approach can optimize site selection, trial design, and other critical elements in clinical tr...

This podcast features malaria experts Caroline Boulton (Global Program Head, Malaria, at Novartis); Sherwin Charles (CEO, Goodbye Malaria); and Carlos Chaccour (Researcher and Visiting Scholar, Navarra Institute for International Development). The conversation delves into the current malaria response, examining shifts in international funding, R&D innovations, drug resistance challenges, emerg...

In this episode, IQVIA MedTech experts Michelle Edwards and Michaela Miller discuss key trends shaping the MedTech industry in 2025. The conversation covers advancements in 3D printing, real-world evidence (RWE), and clinical AI, among others.   Read Ten MedTech Trends to Watch in 2025 to learn more. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA Featured Spea...

This podcast episode features a discussion between Jeff Pilch from IQVIA and Sanjay Mistry from Molnlycke. Together, they explore the journey of how their companies collaborated to solve a significant business problem related to customer master data management (MDM). Sanjay explains the challenges Molnlycke faced in defining and managing customer data across different units, which hindered their a...

On International HPV Awareness Day, Dr. Nicola Paul hosts Dr. Tando Gaqana, a passionate HPV vaccine advocate, and Daniel Mora-Brito, IQVIA's thought leader in global health, to discuss the impact of Human Papillomavirus (HPV) in South Africa, highlighting the importance of vaccination and regular screening to prevent HPV-related conditions in Africa.

This episode focuses on using AI for indication selection and prioritization to optimize the value of clinical development planning.  In this episode you will:   Discover how AI can identify indications with the greatest probability of success and areas of untapped opportunity.  See how AI can be leveraged to prioritize hundreds of indications into high-potential opportunities rapidly.  Learn abou...

In this episode, Ekra Yao shares his view of the ongoing efforts and strategies in the fight against polio in Africa.

In this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics shares her perspectives on the potential of GenAI to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The di...

Join IQVIA Thought Leaders, Kirstie Scott and Stefan Lutzmayer, to explore how to translate the promise of ground-breaking oncology therapies into commercially successful launches. Learn about the evolving oncology landscape, and how to navigate a fluid and challenging commercial environment to achieve Oncology Launch Excellence.